PMID- 23922993 OWN - NLM STAT- MEDLINE DCOM- 20140821 LR - 20240320 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 8 IP - 7 DP - 2013 TI - Amiodarone inhibits apamin-sensitive potassium currents. PG - e70450 LID - 10.1371/journal.pone.0070450 [doi] LID - e70450 AB - BACKGROUND: Apamin sensitive potassium current (I KAS), carried by the type 2 small conductance Ca(2+)-activated potassium (SK2) channels, plays an important role in post-shock action potential duration (APD) shortening and recurrent spontaneous ventricular fibrillation (VF) in failing ventricles. OBJECTIVE: To test the hypothesis that amiodarone inhibits I KAS in human embryonic kidney 293 (HEK-293) cells. METHODS: We used the patch-clamp technique to study I KAS in HEK-293 cells transiently expressing human SK2 before and after amiodarone administration. RESULTS: Amiodarone inhibited IKAS in a dose-dependent manner (IC50, 2.67 +/- 0.25 microM with 1 microM intrapipette Ca(2+)). Maximal inhibition was observed with 50 microM amiodarone which inhibited 85.6 +/- 3.1% of IKAS induced with 1 microM intrapipette Ca(2+) (n = 3). IKAS inhibition by amiodarone was not voltage-dependent, but was Ca(2+)-dependent: 30 microM amiodarone inhibited 81.5+/-1.9% of I KAS induced with 1 microM Ca(2+) (n = 4), and 16.4+/-4.9% with 250 nM Ca(2+) (n = 5). Desethylamiodarone, a major metabolite of amiodarone, also exerts voltage-independent but Ca(2+) dependent inhibition of I KAS. CONCLUSION: Both amiodarone and desethylamiodarone inhibit I KAS at therapeutic concentrations. The inhibition is independent of time and voltage, but is dependent on the intracellular Ca(2+) concentration. SK2 current inhibition may in part underlie amiodarone's effects in preventing electrical storm in failing ventricles. FAU - Turker, Isik AU - Turker I AD - Krannert Institute of Cardiology and Division of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA. FAU - Yu, Chih-Chieh AU - Yu CC FAU - Chang, Po-Cheng AU - Chang PC FAU - Chen, Zhenhui AU - Chen Z FAU - Sohma, Yoshiro AU - Sohma Y FAU - Lin, Shien-Fong AU - Lin SF FAU - Chen, Peng-Sheng AU - Chen PS FAU - Ai, Tomohiko AU - Ai T LA - eng GR - R01HL78932/HL/NHLBI NIH HHS/United States GR - P01 HL078931/HL/NHLBI NIH HHS/United States GR - R01HL71140/HL/NHLBI NIH HHS/United States GR - P01HL78931/HL/NHLBI NIH HHS/United States GR - R01 HL078932/HL/NHLBI NIH HHS/United States GR - R01 HL071140/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20130729 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Anti-Arrhythmia Agents) RN - 0 (KCNN2 protein, human) RN - 0 (Small-Conductance Calcium-Activated Potassium Channels) RN - 24345-16-2 (Apamin) RN - M31FU99E3Y (desethylamiodarone) RN - N3RQ532IUT (Amiodarone) RN - SY7Q814VUP (Calcium) SB - IM MH - Amiodarone/analogs & derivatives/*pharmacology MH - Anti-Arrhythmia Agents/*pharmacology MH - Apamin/*pharmacology MH - Calcium/metabolism MH - Dose-Response Relationship, Drug MH - HEK293 Cells MH - Humans MH - Intracellular Space/metabolism MH - Patch-Clamp Techniques MH - Small-Conductance Calcium-Activated Potassium Channels/*antagonists & inhibitors/genetics/*metabolism MH - Ventricular Fibrillation/metabolism PMC - PMC3726612 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2013/08/08 06:00 MHDA- 2014/08/22 06:00 PMCR- 2013/07/29 CRDT- 2013/08/08 06:00 PHST- 2012/09/05 00:00 [received] PHST- 2013/06/24 00:00 [accepted] PHST- 2013/08/08 06:00 [entrez] PHST- 2013/08/08 06:00 [pubmed] PHST- 2014/08/22 06:00 [medline] PHST- 2013/07/29 00:00 [pmc-release] AID - PONE-D-12-26765 [pii] AID - 10.1371/journal.pone.0070450 [doi] PST - epublish SO - PLoS One. 2013 Jul 29;8(7):e70450. doi: 10.1371/journal.pone.0070450. Print 2013.